Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open-chest Cardiac Surgery (NOVA)



Status:Recruiting
Conditions:Atrial Fibrillation
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:55 - 90
Updated:3/15/2019
Start Date:March 1, 2019
End Date:February 27, 2021
Contact:Clinical Trials Registry Team
Email:IR‐CTRegistration@Allergan.com
Phone:877‐277‐8566

Use our guide to learn which trials are right for you!

A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A (AGN-151607) Injections Into the Epicardial Fat Pads to Prevent Post-Operative Atrial Fibrillation in Patients Undergoing Open-Chest Cardiac Surgery

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group,
dose-ranging study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607)
injections into the epicardial fat pads, foci of ganglionic plexi, to prevent Post-Operative
Atrial Fibrillation (POAF) in patients undergoing open-chest cardiac surgery.


Inclusion Criteria:

- Capable of giving signed informed consent, which includes compliance with the
requirements and restrictions listed in the informed consent form.

- Written informed consent from the participant has been obtained prior to any
study-related procedures

- Written documentation has been obtained in accordance with the relevant country and
local privacy requirements, where applicable (eg. Written Authorization for Use and
Release of Health and Research Study Information [US sites] and written Data
Protection consent (European Union sites).

- Participants who are scheduled to undergo open-chest cardiac surgery. Including
(coronary artery bypass graft (CABG) and/or valve repair/replacement).

- A male participant must agree to use contraception until Day 60 and refrain from
donating sperm during this period.

- A female participant is eligible to participate if she is not pregnant (has a negative
urine pregnancy result prior to randomization) not breastfeeding, and at least 1 of
the following conditions applies:

1. Not a woman of childbearing potential (WOCBP).

2. A WOCBP who agrees to follow the contraceptive guidance until after Day 60.

- In sinus rhythm for the last 48 hours prior to surgery (prior history of paroxysmal
atrial fibrillation (AF) is acceptable).

- Willing to wear an electrocardiogram (ECG) patch for 30 days post-surgery and for 7
days after each study visit

- Able, as assessed by the investigator, and willing to follow study instructions and
likely to complete required study visit.

Exclusion Criteria:

- Any medical condition that may put the participant at increased risk with exposure to
botulinum toxin type A, including diagnosed muscular dystrophy (eg, Duchenne's
muscular dystrophy), myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral
sclerosis, mitochondrial disease, or any other significant disease which might
interfere with neuromuscular function.

- Participants with presence or history of any of the following within 3 months prior to
the Day 1 visit that may indicate a vulnerable respiratory state per the
investigator's clinical judgment: aspiration pneumonia, lower respiratory tract
infections, uncontrolled asthma, severe chronic obstructive pulmonary disease, or
otherwise compromised respiratory function.

- Permanent/persistent atrial fibrillation (AF)

- Has a known allergy or sensitivity to any botulinum toxin type A preparation.

- Has a known allergy or sensitivity to medical adhesive (eg, ECG patch adhesive;
hydrogel-based adhesive).

- Severe (> 55mm) atrial enlargement

- Left ventricular ejection fraction (LVEF) < 25%

- Presence or history of symptomatic atrioventricular block > 1st degree within the last
30 days

- Class I or III antiarrhythmic drugs unless proper washout was documented

- Botulinum toxin type A (of any serotype) use within 6 months of randomization

- Has been immunized for any botulinum toxin type A serotype as determined by
participant medical history

- Preoperative need for inotropes/vasopressors or intra-aortic balloon pump

- Prior cardiac surgery

- History of ablation for AF

- Planned ablation procedure for AF at the time of surgery

- Emergency surgery

- Current enrollment in an investigational drug or device study or participation in such
a study within 30 days of entry into this study

- Impaired prognosis defined as EuroSCORE II greater than 7% perioperative mortality

- Females who are pregnant, nursing, or planning a pregnancy during the study
We found this trial at
9
sites
Durham, North Carolina 27710
(919) 684-8111
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
?
mi
from
Durham, NC
Click here to add this to my saved trials
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
2049 E 100th St
Cleveland, Ohio 44106
(216) 444-2200
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Plano, Texas 75093
?
mi
from
Plano, TX
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
110 Irving Street Northwest
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials